FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernard Bégaud

Research Profile

Geographic Areas

France

Concepts & Ideas

Chemicals & Drugs

Occupations

Pharmacoepidemiology

Activities & Behaviors

Co-author Network

Publications

TOP 3
Nicholas Moore; Georges-Philippe Pageaux; Antoine Pariente; Jacques Bénichou; P Blin; Sinem Ezgi Gulmez; Jérémy Jové; Dominique Larrey; Régis Lassalle; Séverine Lignot; Bernard Bégaud
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.
Antoine Pariente; Francesco Salvo; Frantz Thiessard; Paul Avillach; Bernard Bégaud; Annie Fourrier-Reglat; Françoise Haramburu; Ghada Miremont-Salamé; Nicholas Moore
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
Hélène Théophile; Manon André; Yannick Arimone; Françoise Haramburu; Ghada Miremont-Salamé; Bernard Bégaud
An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernard Bégaud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nicholas Moore; Georges-Philippe Pageaux; Antoine Pariente; Jacques Bénichou; P Blin; Sinem Ezgi Gulmez; Jérémy Jové; Dominique Larrey; Régis Lassalle; Séverine Lignot; Bernard Bégaud
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.
Pharmacoepidemiology and drug safety 2013;22(2):160-7.
2012: Antoine Pariente; Francesco Salvo; Frantz Thiessard; Paul Avillach; Bernard Bégaud; Annie Fourrier-Reglat; Françoise Haramburu; Ghada Miremont-Salamé; Nicholas Moore
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(10):855-64.
2012: Hélène Théophile; Manon André; Yannick Arimone; Françoise Haramburu; Ghada Miremont-Salamé; Bernard Bégaud
An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance.
Journal of clinical epidemiology 2012;65(10):1069-77.
2012: Marie Tournier; Guy-Robert Auleley; Bernard Bégaud; Claudine Blum-Boisgard; Audrey Cougnard; Jean Deligne; Anne C M Thiébaut; Hélène Verdoux
Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.
British journal of clinical pharmacology 2012;74(1):189-96.
2012: Ismaïl Ahmed; Bernard Bégaud; Françoise Haramburu; Carmen Kreft-Jais; Ghada Miremont-Salamé; Frantz Thiessard; Pascale Tubert-Bitter
Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(6):495-506.
2012: Marie-Agnès Bernard; P Blin; Annie Fourrier-Réglat; Nicholas Moore; Alain Weill; Abdelilah Abouelfath; Bernard Bégaud; Jacques Bénichou
Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
Pharmacoepidemiology and drug safety 2012;21(6):573-83.
2012: Sophie Billioti de Gage; Jean-François Dartigues; Tobias Kurth; Fabienne Bazin; Bernard Bégaud; Karine Pérès; Hélène Verdoux; Antoine Pariente
Benzodiazepine use and risk of dementia: prospective population based study.
BMJ (Clinical research ed.) 2012;345():e6231.
2012: Ainiwaer Aikemu; Bernard Bégaud; Bénédicte Berké; Anwar Umar; Halmurat Upur; Abdiryim Yusup; Nicholas Moore
Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice.
BMC complementary and alternative medicine 2012;12():157.
2012: Amélie Daveluy; Aurore Gouraud; Françoise Haramburu; Marie-Laure Laroche; Bénédicte Lebrun-Vignes; Brigitte Milpied; Ghada Miremont-Salamé; Nicholas Moore; Annick Barbaud; Bernard Bégaud; Ecaterina Ciobanu
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
European journal of clinical pharmacology 2012;68(1):101-5.
2011: Hélène Théophile; Joan-Ramon Laporte; Karin-Latry Martin; Nicholas Moore; Bernard Bégaud
The case-population study design: an analysis of its application in pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(10):861-8.
2011: Sinem Ezgi Gulmez; Régis Lassalle; Nicholas Moore; Michel Rossignol; Bernard Bégaud; P Blin; Cécile Droz-Perroteau; Annie Fourrier-Réglat
Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort.
European journal of clinical pharmacology 2011;67(8):833-8.
2011: Hélène Théophile; Abdelilah Abouelfath; Françoise Haramburu; Valentine Kahn; Ghada Miremont-Salamé; Thierry Schaeverbeke; Bernard Bégaud
Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(7):577-85.
2011: Hélène Théophile; Bernard Bégaud; Ghada Miremont-Salamé; Nicholas Moore; Philip Robinson; Françoise Haramburu
Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration.
European journal of clinical pharmacology 2011;67(7):681-6.
2011: Philippe Latry; Bernard Bégaud; Thierry Couffinhal; Bernard Dedieu; Mathieu Molimard; Karin Martin-Latry
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study.
BMC cardiovascular disorders 2011;11():46.
2011: Michel Rossignol; Bernard Bégaud; Bernard Avouac; France Lert; Frédéric Rouillon; Jacques Bénichou; Jacques Massol; Gérard Duru; Anne-Marie Magnier; Didier Guillemot; Lamiae Grimaldi-Bensouda; Lucien Abenhaim
Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France.
BMC musculoskeletal disorders 2011;12():21.
2010: Hélène Théophile; Yannick Arimone; Ghada Miremont-Salamé; Nicholas Moore; Annie Fourrier-Réglat; Françoise Haramburu; Bernard Bégaud
Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(11):1045-54.
2010: Annie Fourrier-Réglat; L Lacoin; A Pariente; R Lassalle; P Robinson; C Droz-Perroteau; Bernard Bégaud; P Blin; nicholas moore
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study.
Clinical pharmacology and therapeutics 2010;88(5):668-75.
2010: Philippe Latry; mathieu molimard; Bernard Bégaud; Karin Martin-Latry
How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database.
European journal of clinical pharmacology 2010;66(7):743-8.
2010: Annie Fourrier-Réglat; Huynh Minh Cuong; Régis Lassalle; Fanny Depont; Philip Robinson; Cécile Droz-Perroteau; Antoine Pariente; Bernard Bégaud; P Blin; Nicholas Moore
Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort.
Pharmacoepidemiology and drug safety 2010;19(5):474-81.
2010: Amélie Daveluy; Ghada Miremont-Salamé; Anne-Cécile Rahis; Jean-Michel Delile; Bernard Bégaud; Jean-Pierre Gachie; Françoise Haramburu
Medicine or ecstasy? The importance of the logo.
Fundamental & clinical pharmacology 2010;24(2):233-7.
2010: David Laharie; Cécile Droz-Perroteau; Jacques Bénichou; Michel Amouretti; P Blin; Bernard Bégaud; Estelle Guiard; Sylvie Dutoit; Stéphanie Lamarque; Yola Moride; Fanny Depont; Annie Fourrier-Réglat; Nicholas Moore
Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.
British journal of clinical pharmacology 2010;69(3):295-302.
2010: Karin Martin-Latry; Bernard Bégaud
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Pharmacoepidemiology and drug safety 2010;19(3):256-65.
2010: Nicholas Moore; Bernard Bégaud
Improving pharmacovigilance in Europe.
BMJ (Clinical research ed.) 2010;340():c1694.
2010: Hélène Verdoux; Audrey Cougnard; G-R Auleley; J Deligne; C Blum-Boisgard; Bernard Bégaud; Marie Tournier
Antipsychotic use patterns in persons initially treated with mood stabilizers: a naturalistic study.
Pharmacopsychiatry 2010;43(1):17-23.
2010: Hélène Verdoux; Marie Tournier; Bernard Bégaud
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies.
Acta psychiatrica Scandinavica 2010;121(1):4-10.
2009: Clementine Nordon; Karin Martin-Latry; Laurence de Roquefeuil; Philippe Latry; Bernard Bégaud; Bruno Falissard; Frederic Rouillon; Hélène Verdoux
Risk of death related to psychotropic drug use in older people during the European 2003 heatwave: a population-based case-control study.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2009;17(12):1059-67.
2009: Hélène Théophile; Ghada Miremont-Salamé; Abdelilah Abouelfath; Bernard Bégaud; Françoise Haramburu
Patterns of laxative use in self-medication.
The Annals of pharmacotherapy 2009;43(12):2122-3.
2009: Ismaïl Ahmed; Françoise Haramburu; Annie Fourrier-Réglat; Frantz Thiessard; Carmen Kreft-Jais; Ghada Miremont-Salamé; Bernard Bégaud; Pascale Tubert-Bitter
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
Statistics in medicine 2009;28(13):1774-92.
2009: Marie Baumevieille; Amélie Daveluy; Catherine Maurain; Bernard Bégaud; Françoise Haramburu
Medicines submitted to narcotics regulations in France, 1992-2007.
Fundamental & clinical pharmacology 2009;23(3):345-9.
2009: Rajaa Lagnaoui; Marie Tournier; Yola Moride; Christina Wolfson; Thierry Ducruet; Bernard Bégaud; nicholas moore
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use.
Age and ageing 2009;38(2):226-8.
2009: Michel Rossignol; Abdelilah Abouelfath; Regis Lassalle; Yvon Merlière; Cécile Droz; Bernard Bégaud; Fanny Depont; Yola Moride; Patrick Blin; nicholas moore; Annie Fourrier-Réglat
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.
British journal of clinical pharmacology 2009;67(1):118-24.
2008: A Grolleau; Audrey Cougnard; Bernard Bégaud; Hélène Verdoux
[Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
L'Encéphale 2008;34(4):352-9.
2008: Fleur Grégoire; Antoine Pariente; Annie Fourrier-Reglat; Françoise Haramburu; Bernard Bégaud; nicholas moore
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.
British journal of clinical pharmacology 2008;66(1):142-5.
2008: Annie Fourrier-Réglat; Cécile Droz-Perroteau; Jacques Bénichou; Fanny Depont; Michel Amouretti; Bernard Bégaud; Yola Moride; Patrick Blin; nicholas moore
Impact of prescriber nonresponse on patient representativeness.
Epidemiology (Cambridge, Mass.) 2008;19(2):186-90.
2008: A Grolleau; Audrey Cougnard; Bernard Bégaud; Hélène Verdoux
Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population.
Acta psychiatrica Scandinavica 2008;117(1):20-7.
2007: Marieke Grenouillet-Delacre; Hélène Verdoux; nicholas moore; Françoise Haramburu; Ghada Miremont-Salamé; Gabriel Etienne; Philip Robinson; Didier Gruson; Gilles Hilbert; Claude Gabinski; Bernard Bégaud; mathieu molimard
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.
Intensive care medicine 2007;33(12):2150-7.
2007: Yannick Arimone; Ghada Miremont-Salamé; Françoise Haramburu; mathieu molimard; nicholas moore; Annie Fourrier-Réglat; Bernard Bégaud
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
British journal of clinical pharmacology 2007;64(4):482-8.
2007: Karin Martin-Latry; Marie-Pierre Goumy; Philippe Latry; Claude Gabinski; Bernard Bégaud; Isabelle Faure; Hélène Verdoux
Psychotropic drugs use and risk of heat-related hospitalisation.
European psychiatry : the journal of the Association of European Psychiatrists 2007;22(6):335-8.
2007: Fanny Depont; Annie Fourrier; Y Merlière; C Droz; M Amouretti; Bernard Bégaud; J Bénichou; Yola Moride; G P Velo; M Sturkenboom; P Blin; nicholas moore
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Pharmacoepidemiology and drug safety 2007;16(8):891-900.
2007: Marie Tournier; mathieu molimard; Karine Titier; Audrey Cougnard; Bernard Bégaud; Georges Gbikpi-Benissan; Hélène Verdoux
Accuracy of information on substance use recorded in medical charts of patients with intentional drug overdose.
Psychiatry research 2007;152(1):73-9.
2007: Bernard Bégaud
[A homage to Professeur Paul Montrastruc].
Thérapie 2007;62(3):275-6.
2007: Fanny Depont; Annie Fourrier; Y Merlière; C Droz; M Amouretti; Bernard Bégaud; J Bénichou; Yola Moride; P Blin; nicholas moore
The CADEUS study: methods and logistics.
Pharmacoepidemiology and drug safety 2007;16(5):571-80.
2007: K Martin; Philippe Latry; Y Moride; Bernard Bégaud
[Where can we find French data for pharmacoepidemiology? A few thoughts].
Revue d'épidémiologie et de santé publique 2007;55(1):58-63.
2007: Marie Baumevieille; Bernard Bégaud; Catherine Maurain
[Charter of medicines promotion and rational use by physicians].
Thérapie 2007;62(1):39-44.
2006: Rajaa Lagnaoui; Marie Baumevielle; Bernard Bégaud; Pierre Pouyanne; Gwenaëlle Maurice; Fanny Depont; nicholas moore
Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France.
Thérapie 2006;61(4):341-6.
2006: Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; mathieu molimard; nicholas moore; Françoise Haramburu
A new method for assessing drug causation provided agreement with experts' judgment.
Journal of clinical epidemiology 2006;59(3):308-14.
2006: Hélène Verdoux; Marie Tournier; Audrey Cougnard; Karin Martin; Bernard Bégaud
[Pharmacoepidemiology of psychotropic medication: utilisation and impact in real-life conditions].
Thérapie 2006;61(1):17-22.
2005: Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(6):403-14.
2005: Emmanuel Roux; Frantz Thiessard; Annie Fourrier; Bernard Bégaud; Pascale Tubert-Bitter
Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance.
IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society 2005;9(4):518-27.
2005: Hélène Verdoux; Audrey Cougnard; Sabrina Grolleau; Bernard Bégaud
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.
Schizophrenia research 2005;77(1):107-9.
2005: Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; nicholas moore; mathieu molimard; Françoise Haramburu
Agreement of expert judgment in causality assessment of adverse drug reactions.
European journal of clinical pharmacology 2005;61(3):169-73.
2005: Edwige Apretna; Françoise Haramburu; Florence Taboulet; Bernard Bégaud
[Medical and socio-economical impact of drug-induced adverse reactions].
Presse médicale (Paris, France : 1983) 2005;34(4):271-6.
2005: Frantz Thiessard; Emmanuel Roux; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Françoise Haramburu; Pascale Tubert-Bitter; Bernard Bégaud
Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
Drug safety : an international journal of medical toxicology and drug experience 2005;28(8):731-40.
2005: C Ricard; Karin Martin; Marie Tournier; Bernard Bégaud; Hélène Verdoux
[A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
L'Encéphale 2005;31(1 Pt 1):98-101.
2005: Mathilde Daurel-Receveur; Ghada Miremont-Salamé; Annie Fourrier; Pascal Auriche; nicholas moore; Bernard Bégaud; Françoise Haramburu
[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France].
Thérapie 2005;60(1):61-5.
2005: Annie Fourrier-Réglat; Ségolène de Bailliencourt; mathieu molimard; Philippe Latry; nicholas moore; Claude Peter; Bernard Bégaud
[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France].
Thérapie 2005;60(1):25-9.
2005: Muriel Vray; Jean-Michel Joubert; Eveline Eschwège; François Liard; Francis Fagnani; François Montestruc; Sophie Fages; Bernard Bégaud
[Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat].
Thérapie 2005;60(1):17-24.
2005: Bernard Bégaud; Karin Martin; Abdelilah Abouelfath; Pascale Tubert-Bitter; nicholas moore; Yola Moride
An easy to use method to approximate Poisson confidence limits.
European journal of epidemiology 2005;20(3):213-6.
2005: Karin Martin; Yola Moride; Colleen Metge; nicholas moore; Bernard Bégaud
Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis.
The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2005;31(1):37-9.
2005: Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; mathieu molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; nicholas moore
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(1):35-51.
2005: Anwar Umar; Fanny Depont; Alain Jacquet; Séverine Lignot; Marie Claude Segur; Michel Boisseau; Bernard Bégaud; nicholas moore
Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial.
Thrombosis research 2005;115(1-2):31-7.
2004: Bernard Bégaud; Hélène Verdoux
Did the US boycott of French products spread to include scientific output?
BMJ (Clinical research ed.) 2004;329(7480):1430-1.
2004: Muriel Vray; Jean-Michel Joubert; Eveline Eschwège; François Liard; Francis Fagnani; Bénédicte Commenges; Ghislaine Steinberg; Bernard Bégaud
[Methodology and quality control in EPIGRAM, a pharmacoepidemiological study of obesity in general practice].
Thérapie 2004;59(6):573-9.
2004: Anwar Umar; Michel Boisseau; Abdiryim Yusup; Halmurat Upur; Bernard Bégaud; nicholas moore
Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
Fundamental & clinical pharmacology 2004;18(5):559-63.
2004: nicholas moore; Hélène Diris; Karin Martin; Raymond Viale; Annie Fourrier; Yola Moride; Bernard Bégaud
NSAID use profiles derived from reimbursement data in France.
Thérapie 2004;59(5):541-6.
2004: Rajaa Lagnaoui; Fanny Depont; Annie Fourrier; Abdelilah Abouelfath; Bernard Bégaud; Hélène Verdoux; nicholas moore
Patterns and correlates of benzodiazepine use in the French general population.
European journal of clinical pharmacology 2004;60(7):523-9.
2004: Hélène Verdoux; Bernard Bégaud
Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?
The British journal of psychiatry : the journal of mental science 2004;185():93-4.
2004: Vincent Pradel; Xavier Thirion; Eléonore Ronfle; Alain Masut; Joëlle Micallef; Bernard Bégaud
Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database.
Pharmacoepidemiology and drug safety 2004;13(7):473-81.
2004: Marcelle-Diane Matsika; Marie Tournier; Rajaa Lagnaoui; Fabienne Pehourcq; mathieu molimard; Bernard Bégaud; Hélène Verdoux; nicholas moore
Comparison of patient questionnaires and plasma assays in intentional drug overdoses.
Basic & clinical pharmacology & toxicology 2004;95(1):31-7.
2004: Karin Martin; Bernard Bégaud; Hélène Verdoux; N Lechevallier; Philippe Latry; nicholas moore
Patterns of risperidone prescription: a utilization study in south-west France.
Acta psychiatrica Scandinavica 2004;109(3):202-6.
2004: Hélène Théophile; Bernard Bégaud; Karin Martin; Juan Ramon Laporte; Dolores Capella
Incidence of agranulocytosis in Southwest France.
European journal of epidemiology 2004;19(6):563-5.
2004: Karin Martin; Bernard Bégaud; Philippe Latry; Ghada Miremont-Salamé; Annie Fourrier; nicholas moore
Differences between clinical trials and postmarketing use.
British journal of clinical pharmacology 2004;57(1):86-92.
2003: Marie Tournier; mathieu molimard; Abdelilah Abouelfath; Audrey Cougnard; Annie Fourrier; Françoise Haramburu; Bernard Bégaud; Hélène Verdoux
Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patients.
Acta psychiatrica Scandinavica 2003;108(6):410-8.
2003: Bernard Bégaud; Annie Fourrier; nicholas moore; Yola Moride
The delusion of reducing sample size.
European journal of clinical pharmacology 2003;59(8-9):711-2.
2003: Rajaa Lagnaoui; nicholas moore; Yola Moride; Ghada Miremont-Salamé; Bernard Bégaud
Benzodiazepine utilization patterns in Alzheimer's disease patients.
Pharmacoepidemiology and drug safety 2003;12(6):511-5.
2003: nicholas moore; Pascale Tubert-Bitter; Annie Fourrier; Bernard Bégaud
A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.
Journal of clinical epidemiology 2003;56(5):433-5.
2003: Jacques Dangoumau; Françoise Haramburu; Bernard Bégaud
[Some questions about statins].
Thérapie 2003;58(1):91-5.
2002: Bernard Bégaud; Karin Martin; Annie Fourrier; Françoise Haramburu
Does age increase the risk of adverse drug reactions?
British journal of clinical pharmacology 2002;54(5):550-2.
2002: Bernard Bégaud; Ulf Bergman; Hans-Georg Eichler; Hubert G M Leufkens; Peter Meier
Drug reimbursement: indicators of inappropriate resource allocation.
British journal of clinical pharmacology 2002;54(5):528-34.
2002: Bernard Bégaud; Karin Martin; Françoise Haramburu; nicholas moore
Rates of spontaneous reporting of adverse drug reactions in France.
JAMA : the journal of the American Medical Association 2002;288(13):1588.
2002: Bernard Bégaud
[Epidemiology of leg ulcers].
Annales de dermatologie et de vénéréologie 2002;129(10 Pt 2):1225-6.
2002: Emmanuel Touzé; Annie Fourrier; Cécile Rue-Fenouche; Véronique Rondé-Oustau; Isabelle Jeantaud; Bernard Bégaud; Annick Alpérovitch
Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.
Neuroepidemiology 2002;21(4):180-6.
2002: Rajaa Lagnaoui; Bernard Bégaud; nicholas moore; Anicet Chaslerie; Annie Fourrier; Luc Letenneur; Jean-François Dartigues; Yola Moride
Benzodiazepine use and risk of dementia: a nested case-control study.
Journal of clinical epidemiology 2002;55(3):314-8.
2001: Rajaa Lagnaoui; nicholas moore; Maïté Longy-Boursier; Marie Baumevieille; Bernard Bégaud
Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.
Pharmacoepidemiology and drug safety 2001;10(6):531-5.
2001: Rajaa Lagnaoui; nicholas moore; Jean-François Dartigues; Annie Fourrier; Bernard Bégaud
Benzodiazepine use and wine consumption in the French elderly.
British journal of clinical pharmacology 2001;52(4):455-6.
2001: Annie Fourrier; Luc Letenneur; Jean-François Dartigues; nicholas moore; Bernard Bégaud
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.
European journal of clinical pharmacology 2001;57(5):419-25.
2001: Isabelle Jeantaud; Françoise Haramburu; Bernard Bégaud
[Benzodiazepine consumption: survey of community pharmacies in Aquitaine].
Thérapie 2001;56(4):415-9.
2001: C Lacoste-Roussillon; Pierre Pouyanne; Françoise Haramburu; G Miremont; Bernard Bégaud
Incidence of serious adverse drug reactions in general practice: a prospective study.
Clinical pharmacology and therapeutics 2001;69(6):458-62.
2001: nicholas moore; C Pierfitte; Fabienne Pehourcq; Rajaa Lagnaoui; Bernard Bégaud
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.
Clinical pharmacology and therapeutics 2001;69(6):445-50.
2001: Annie Fourrier; Bernard Bégaud; Annick Alpérovitch; Marie-Hélène Verdier-Taillefer; Emmanuel Touzé; Nicole Decker; Jean-Louis Imbs
Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.
British journal of clinical pharmacology 2001;51(5):489-90.
2001: C Pierfitte; G Macouillard; M Thicoïpe; A Chaslerie; Fabienne Pehourcq; M Aïssou; B Martinez; Rajaa Lagnaoui; Annie Fourrier; Bernard Bégaud; Jacques Dangoumau; nicholas moore
Benzodiazepines and hip fractures in elderly people: case-control study.
BMJ (Clinical research ed.) 2001;322(7288):704-8.
2001: Marie Baumevieille; G Miremont; Françoise Haramburu; C Maurain; Bernard Bégaud
[The French system of evaluation of dependence: establishment in a legal system].
Thérapie 2001;56(1):15-22.
2000: Pascale Tubert-Bitter; R Manfredi; J Lellouch; Bernard Bégaud
Sample size calculations for risk equivalence testing in pharmacoepidemiology.
Journal of clinical epidemiology 2000;53(12):1268-74.
2000: C Pierfitte; R J Royer; nicholas moore; Bernard Bégaud
The link between sunshine and phototoxicity of sparfloxacin.
British journal of clinical pharmacology 2000;49(6):609-12.
2000: Rajaa Lagnaoui; nicholas moore; J Fach; Maïté Longy-Boursier; Bernard Bégaud
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.
European journal of clinical pharmacology 2000;56(2):181-6.
2000: Pierre Pouyanne; Françoise Haramburu; Jean-Louis Imbs; Bernard Bégaud
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.
BMJ (Clinical research ed.) 2000;320(7241):1036.
2000: Françoise Haramburu; Pierre Pouyanne; Jean-Louis Imbs; Jean-Pierre Blayac; Bernard Bégaud
[Incidence and prevalence of adverse drug reactions].
Presse médicale (Paris, France : 1983) 2000;29(2):111-4.
2000: Bernard Bégaud; Jacques Dangoumau
[Pharmacoepidemiology: definitions, problems, methodology].
Thérapie 2000;55(1):113-7.
2000: Annie Fourrier; Isabelle Gasquet; MP Allicar; Myriam Bouhassira; J P Lépine; Bernard Bégaud
Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists.
British journal of clinical pharmacology 2000;49(1):80-6.
1999: L Abenhaim; nicholas moore; Bernard Bégaud
The role of pharmacoepidemiology in pharmacovigilance: a conference at the 6th ESOP Meeting, Budapest, 28 September 1998.
Pharmacoepidemiology and drug safety 1999;8 Suppl 1():S1-7.
1999: Rajaa Lagnaoui; Damien Barcat; J Fach; Bernard Bégaud; M Longy-Boursier
[Dextropropoxyphene-paracetamol and general convulsive crisis: case report].
Thérapie 1999;54(2):262-3.
1999: Isabelle Jeantaud; Françoise Haramburu; Bernard Bégaud
[Substitution treatment for opiate dependence: survey of community pharmacies in Aquitaine].
Thérapie 1999;54(2):251-5.
1999: C Pierfitte; Bernard Bégaud; Rajaa Lagnaoui; nicholas moore
Is reporting rate a good predictor of risks associated with drugs?
British journal of clinical pharmacology 1999;47(3):329-31.
1999: Jean-Louis Imbs; Pierre Pouyanne; Françoise Haramburu; Marie Welsch; Nicole Decker; Jean-Pierre Blayac; Bernard Bégaud
[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].
Thérapie 1999;54(1):21-7.
1997: nicholas moore; C Kreft-Jais; Françoise Haramburu; C Noblet; M Andrejak; Michel Ollagnier; Bernard Bégaud
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.
British journal of clinical pharmacology 1997;44(5):513-8.
1997: Françoise Haramburu; Bernard Bégaud; Yola Moride
Temporal trends in spontaneous reporting of unlabelled adverse drug reactions.
British journal of clinical pharmacology 1997;44(3):299-301.
1997: Marie Baumevieille; Françoise Haramburu; Bernard Bégaud
Abuse of prescription medicines in southwestern France.
The Annals of pharmacotherapy 1997;31(7-8):847-50.
1997: Yola Moride; Françoise Haramburu; A A Requejo; Bernard Bégaud
Under-reporting of adverse drug reactions in general practice.
British journal of clinical pharmacology 1997;43(2):177-81.
1996: Lucien Abenhaim; Yola Moride; F Brenot; S Rich; J Benichou; Xavier Kurz; T Higenbottam; C Oakley; E Wouters; M Aubier; G Simonneau; Bernard Bégaud
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
The New England journal of medicine 1996;335(9):609-16.
1994: P Tubert-Bitter; Bernard Bégaud; Yola Moride; Lucien Abenhaim
Sample size calculations for single group post-marketing cohort studies.
Journal of clinical epidemiology 1994;47(4):435-9.
1994: Bernard Bégaud; A Chaslerie; Françoise Haramburu
[Organization and results of drug vigilance in France].
Revue d'épidémiologie et de santé publique 1994;42(5):416-23.
1994: G Miremont; Françoise Haramburu; Bernard Bégaud; J C Péré; J Dangoumau
Adverse drug reactions: physicians' opinions versus a causality assessment method.
European journal of clinical pharmacology 1994;46(4):285-9.
1993: Françoise Haramburu; E Abraham; Bernard Bégaud
[Users of a regional center of pharmacovigilance].
Thérapie 1993;48(5):475-7.
1993: Françoise Haramburu; G Miremont; A Chaslerie; Bernard Bégaud; J Dangoumau
Efficiency of medical journals for pharmacovigilance.
Lancet 1993;341(8851):1030-1.
1992: P Tubert; Bernard Bégaud; J C Péré; Françoise Haramburu; J Lellouch
Power and weakness of spontaneous reporting: a probabilistic approach.
Journal of clinical epidemiology 1992;45(3):283-6.
1991: P Tubert; Bernard Bégaud; Françoise Haramburu; J C Péré
Spontaneous reporting: how many cases are required to trigger a warning?
British journal of clinical pharmacology 1991;32(4):407-8.
1990: J C Péré; Françoise Haramburu; G Salamé; A Chaslerie; H Die-Kakou; A Pelletier; N Delmas; Bernard Bégaud
[Computerized data processing in the Pharmacovigilance Center of Bordeaux-Aquitaine. Analysis of clientele of the Center].
Thérapie 1990;45(5):391-7.
1990: Françoise Haramburu; Bernard Bégaud; J C Péré
Comparison of 500 spontaneous and 500 published reports of adverse drug reactions.
European journal of clinical pharmacology 1990;39(3):287-8.
1987: J C Péré; Françoise Haramburu; Bernard Bégaud; C Barat; B Laborde; H Albin
[Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
Thérapie 1987;42(4):351-8.
1987: Bernard Bégaud; J C Péré; P Tubert; C Barat; Françoise Haramburu; H Albin
[Information centers on undesirable effects of drugs: also on alerting function].
Thérapie 1987;42(2):231-7.
1987: Françoise Haramburu; Bernard Bégaud; J C Péré; H Albin
[Adverse effects of orphan drugs].
Thérapie 1987;42(1):63.
1987: J C Péré; Bernard Bégaud; Françoise Haramburu; H Albin
[Record linkage: a technic in drug surveillance].
Thérapie 1987;42(1):59-62.
1985: J C Péré; M H Godin; Bernard Bégaud; Françoise Haramburu; H Albin
[Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods].
Thérapie 1985;40(5):307-12.
1984: J C Péré; Bernard Bégaud; Françoise Haramburu; H Albin
[Methods for studying the adverse effects of drugs. II. Profile and comparison of 5 methods for establishing causality].
Thérapie 1984;39(4):369-78.